SOLITARY BONE PLASMACYTOMA

Clinical trials for SOLITARY BONE PLASMACYTOMA explained in plain language.

Never miss a new study

Get alerted when new SOLITARY BONE PLASMACYTOMA trials appear

Sign up with your email to follow new studies for SOLITARY BONE PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Pronged attack aims to stop rare bone cancer from spreading

Disease control Recruiting now

This study is testing whether adding a new type of antibody drug to standard radiation treatment can better control a rare bone cancer called solitary bone plasmacytoma. The goal is to prevent the cancer from progressing into a more serious disease called multiple myeloma. The tr…

Matched conditions: SOLITARY BONE PLASMACYTOMA

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 25, 2026 14:09 UTC

SOLITARY BONE PLASMACYTOMA

Get alerted when new SOLITARY BONE PLASMACYTOMA trials appear

New Two-Pronged attack aims to stop rare bone cancer from spreading